Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 6;3(4):553-561.
doi: 10.1016/j.trci.2017.02.003. eCollection 2017 Nov.

Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes

Ryan M Carnahan  1 , Grant D Brown  2 , Elena M Letuchy  1 , Linda M Rubenstein  1 , Brian M Gryzlak  1 , Marianne Smith  3 , Jeffrey C Reist  4 , Michael W Kelly  4 , Susan K Schultz  5   6 , Michelle T Weckmann  5   7   8 , Elizabeth A Chrischilles  1
Affiliations

Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes

Ryan M Carnahan et al. Alzheimers Dement (N Y). .

Abstract

Introduction: Antipsychotics are used for managing behavioral and psychological symptoms of dementia (BPSD) but have risks. Anticholinergics can worsen outcomes in dementia. The Improving Antipsychotic Appropriateness in Dementia Patients educational program (IA-ADAPT) and Centers for Medicare and Medicaid Services Partnership to Improve Dementia Care (CMS Partnership) promote improved care for BPSD. The purpose of this study was to evaluate the impact of these programs on medication use and BPSD among nursing home residents.

Methods: This quasi-experimental longitudinal study used Medicare and assessment data for Iowa nursing home residents from April 2011 to December 2012. Residents were required to be eligible for six continuous months for inclusion. Antipsychotic use and anticholinergic use were evaluated on a monthly basis, and changes in BPSD were tracked using assessment data. Results are presented as odds ratios (ORs) per month after exposure to the IA-ADAPT or the start of the CMS Partnership.

Results: Of 426 eligible Iowa nursing homes, 114 were exposed to the IA-ADAPT in 2012. Nursing home exposure to the IA-ADAPT was associated with reduced antipsychotic use (OR [95% CI] = 0.92 [0.89-0.95]) and anticholinergic use (OR [95% CI] = 0.95 [0.92-0.98]), reduced use of excessive antipsychotic doses per CMS guidance (OR [95% CI] = 0.80 [0.75-0.86]), increased odds of a potentially appropriate indication among antipsychotic users (OR [95% CI] = 1.04 [1.00-1.09]), and decreased documentation of verbal aggression (OR [95% CI] = 0.96 [0.94-0.99]). Facilities with two or more IA-ADAPT exposures had greater reductions in antipsychotic and anticholinergic use than those with only one. The CMS Partnership was associated with reduced antipsychotic use (OR [95% CI] = 0.96 [0.94-0.98]) and decreased documentation of any measured BPSD (OR [95% CI] = 0.98 [0.97-0.99]) as well as delirium specifically (OR [95% CI] = 0.98 [0.96-0.99]).

Discussion: This study suggests that the IA-ADAPT and the CMS Partnership improved medication use with no adverse impact on BPSD.

Keywords: Anticholinergics; Antipsychotics; Dementia; Education; Nursing home.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Department of Health. The Use of Antipsychotic Medication for People With Dementia: Time for Action. A Report for the Minister of State for Care Services by Professor Sube Banerjee. Available at: https://www.rcpsych.ac.uk/pdf/Antipsychotic%20Bannerjee%20Report.pdf. Accessed January 10, 2017.
    1. Jeste D.V., Blazer D., Casey D., Meeks T., Salzman C., Schneider L. ACNP white paper: update on the use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology. 2008;33:957–970. - PMC - PubMed
    1. Meeks T.W., Jeste D.V. Beyond the black box: what is the role for antipsychotics in dementia? Curr Psychiatr. 2008;7:50–65. - PMC - PubMed
    1. Chen Y., Briesacher B.A., Field T.S., Tjia J., Lau D.T., Gurwitz J.H. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med. 2010;170:89–95. - PMC - PubMed
    1. Maglione M., Ruelaz Maher A., Hu J., Wang Z., Shanman R., Shekelle P.G. Agency for Healthcare Research and Quality; Rockville, MD: 2011. Off-Label Use of Atypical Antipsychotics: An Update. Comparative Effectiveness Review No. 43.https://www.effectivehealthcare.ahrq.gov/ehc/products/150/778/CER43_Off-... Prepared by the Southern California Evidence-based Practice Center under Contract No. HHSA290-2007-10062-1. Available at: - PubMed